In Brief: U.S. Surgical
This article was originally published in The Gray Sheet
Executive Summary
U.S. Surgical: Company's Vascular Therapies division rolls out the Paragon coronary stent in Europe following receipt of the CE mark, the company says. The martinistic nitinol balloon-expandable stent is a next-generation version of Progressive Angioplasty Systems' ACT-One, which was launched in international markets in mid-1996. USSC acquired PAS on Sept. 22 for $78 mil. in USSC stock -- including a $3 mil. milestone payment -- and a potential payment of an additional $72 mil. in stock if and when certain milestones and sales objectives are met through 2003 ("The Gray Sheet" Sept. 29, I&W-10)...